Dr. John Cush RheumNow
5 years 8 months ago
Abrupt Cessation of Long-Term Opioid Prescribing Common
Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed.
https://t.co/bCnaJHECd0 https://t.co/ermkbK6LMN
Dr. John Cush RheumNow
5 years 8 months ago
RheumNow Podcast – Tofacitinib Safety Concerns
Dr. Jack Cush reviews and discusses the news and journal reports from the past week on RheumNow.
https://t.co/7RDZ0avZLC https://t.co/iUJFuf8PNj
Dr. John Cush RheumNow
5 years 8 months ago
QD Clinic - What Were You Thinking
Pet Peeve Issues in Patient Care
https://t.co/BpjXbsdWr5
Dr. John Cush RheumNow
5 years 8 months ago
HCQ Fails to Prevent COVID-19
Mounting evidence shows that HCQ is ineffective in COVID-19 infection; and now the NEJM reports that HCQ given as post-COVID exposure therapy failed to prevent SARS-CoV-2 infection or symptomatic Covid-19 in healthy persons.
https://t.co/lt71GAtL3D https://t.co/VzmJgQlrrG
Dr. John Cush RheumNow
5 years 8 months ago
Cardiac and Cancer Signals Tofacitinib Safety Alert from FDA
The FDA has notified healthcare professionals of a safety alert concerning tofacitinib (Xeljanz) when given to at-risk rheumatoid arthritis patients.
https://t.co/RJD8CMouHK https://t.co/bipwWlIhiB
Dr. John Cush RheumNow
5 years 8 months ago
PSOLAR study of 298 pregnancies in 220 women with mod-severe psoriasis. 82% resulted in live births and rates of spontaneous abortion and congenital anomalies same as US population. Biologic exposure pregnancy outcomes same as those not on biologics https://t.co/GKXyDGRILD
Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed.
Dr. John Cush RheumNow
5 years 8 months ago
OpenSAFELY analysis shows that NSAIDs safe w/ COVID. Study 1: 1/2 million NSAID users vs ~2 mill non-users found no difference in COVID-19 death (HR 0.96); Study 2: 1.7 million RA/OA pts, 10% on NSAIDs had a lower risk of COVID-19 death (HR 0.78) https://t.co/1f3JBmaf2e
Dr. John Cush RheumNow
5 years 8 months ago
More on Vagal Nerve Stimulation in RA (https://t.co/OykGWP76qd) The device used was an earbud, designed to deli)ver electrical pulse sequences to target the cholinergic anti-inflammatory pathway. They called this neural input methodology, e-mmunotherapy https://t.co/iubW0sZgIs https://t.co/cKlzRXKkLT
Dr. Jack Cush reviews and discusses the news and journal reports from the past week on RheumNow.com.
Dr. John Cush RheumNow
5 years 8 months ago
Adverse Events with Anti-malarials during the COVID Pandemic
Despite very preliminary mixed results, the endorsement of chloroquine and hydroxychloroquine use to treat COVID-19 led substantial use (and drug shortages) for these drugs.
https://t.co/UQYo3a8ZKI
There is a preponderance and mounting evidence that hydroxychloroquine is ineffective in COVID-19 infection; and now the NEJM reports a the results of a trial where HCQ given as post-COVID exposure therapy failed to prevent SARS-CoV-2 infection or symptomatic Covid-19 in healthy persons.
